ODDB.org: Open Drug Database | Drugs | Information for professionals

Search result - IPro for Corgard® 60/120

Information for professionals for Corgard® 60/120:

Bristol-Myers Squibb SA

Complete information for professionals	DDD	Print
Galenic Form / Therapeutic Group	Composition.	Effects	Pharm.kinetik	Indication.	Usage	Restrictions.	Unwanted effects
Interactions.	Overdose	Other advice	Swissmedic-Nr.	Last update of information

C07AA12 - Nadolol

ATC-DDD Version 2016. Source: WHO

C - Cardiovascular System

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.

C07 - Beta Blocking Agents

C07A - Beta Blocking Agents

All plain beta blocking agents are classified in this group.
Labetalol, and carvedilol are classified in C07AG - Alpha- and beta blocking agents.
Beta blocking agents in combination with ACE inhibitors are classified in C09BX - ACE inhibitors, other combinations.
Beta blocking agents in combination with ARBs are classified in C09DX - Angiotensin II receptor blockers (ARBs), other combinations.

The DDDs are based on the treatment of mild-moderate hypertension.
The DDDs for oral and parenteral formulations are equal, even if the parenteral preparations are used for the initial treatment of arrhythmias. Exception: practolol.

C07AA - Beta Blocking Agents, Non-Selective

All plain non-selective beta blocking agents are classified in this group.

C07AA12 - Nadolol

Dose	Route of administration	Note
	O

2025	©ywesee GmbH